Brussels-based MAASH secures €12.15 million to take mycoprotein production to industrial scale
MAASH, a Brussels-based fermentation company specialising in the development and production of mycoproteins for the food industry, has secured a €12.15 million funding package combining equity investment and public financing. The package includes a €5.85 million equity raise from five new investors: Ambra Capital, InvestPro, Bpifrance, Amorçage Industriel, Nordzucker and Tereos. It also includes…
Brussels-based fermentation company MAASH has secured €12.15 million in funding to bring mycoprotein production to industrial scale. The investment package, consisting of equity and public financing, includes a €5.85 million equity raise from five new investors and €4.3 million from Bpifrance through the Première Usine programme and a loan.
Founded in 2021 by Frédéric Van Gansberghe and Gaspard Gilbert, MAASH specializes in developing mycoprotein for the food industry, using precise fermentation control to maintain functional and sensory qualities. With its new CEO, Samah Garringer, who brings over 25 years of international experience, MAASH will transition from project development to execution, aiming to launch a 12 m³ demonstration plant in Carling-Saint-Avold, France, and scale up to 10,000 tons of annual production.
Written by urgent.news from EU-Startups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
